Exhibit 10.1
October 1, 2016
Michael Lewis, Ph.D.
Bio Diligence Partners, Inc.,
This letter shall serve as a twelfth amendment to the Services Agreement dated July 2, 2004. It is hereby agreed to extend the Agreement from October 1, 2016 to July 1, 2017. Compensation described in Exhibit A of the Agreement, as previously amended, will continue at the rate of $157,500.00 per annum and paid on a monthly basis. The reimbursement for 100% of the health insurance cost shall continue, paid quarterly.
All other sections of the Agreement continue as written.
| Cara Therapeutics, Inc. | ||
| By: | /s/ Derek Chalmers | |
| Name: | Derek Chalmers, Ph.D., D.Sc. | |
| Title: | President & CEO | |
| Bio Diligence Partners, Inc. | ||
| By: | /s/ Michael Lewis | |
| Name: | Michael Lewis, Ph.D. | |
| Title: | President | |
